Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.88
0.10 (12.81%)
At close: Aug 15, 2025, 3:59 PM
0.88
0.02%
After-hours: Aug 15, 2025, 07:16 PM EDT

Sutro Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-11.5M -75.97M -72.44M -48.79M -48.02M -58.21M 31.07M -49.28M -38.52M -50.05M -34.59M -19.49M -26.01M -39.11M -38.13M -30.9M -6.15M -30.36M
Depreciation & Amortization
1.9M 1.9M 1.87M 1.8M 1.79M 1.76M 1.73M 1.74M 1.73M 1.61M 1.53M 1.44M 1.4M 1.33M 1.31M 1.12M 1.12M 1.29M
Stock-Based Compensation
5.26M 5.54M 5.92M 6.54M 6.16M 6.07M 6.22M 6M 6.66M 6.02M 5.85M 6.78M 6.7M 6.97M 6.89M 6.5M 5.91M 3.95M
Other Working Capital
-52.3M -2.32M -17.89M -7.29M 25.42M -19.5M -6.19M 8.96M -1.16M -21.86M 16.37M -5.33M 94.1M -4.86M 477K -487K -1.53M -11.07M
Other Non-Cash Items
10.19M 9.79M 8.66M -16.95M 1.15M 2.26M 21.71M 7.39M 1.23M 5.83M -16.21M -2.85M 4.65M 777K 1.84M 4.04M 255K 28K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -25.08M -3.09M -10.16M n/a n/a n/a n/a n/a 3.37M -3.69M -3.63M 11.19M
Change in Working Capital
-50.58M -9.15M -15.73M -7.12M 48.37M -16.62M -21.58M 3.74M 7.88M -24.41M 19.57M 79.98M 10.09M -5.22M 3.13M -1.46M -2.77M -16.53M
Operating Cash Flow
-44.72M -67.88M -71.74M -64.52M 9.46M -64.74M 14.07M -33.5M -31.2M -60.99M -23.86M 65.85M -3.19M -35.26M -21.58M -24.41M -5.26M -30.43M
Capital Expenditures
-86K -1.17M -1.07M -828K -756K -446K -1.44M -328K -1.6M -942K -3.37M -738K -2.2M -1.55M -2.54M -5M -5.41M -2.38M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 22.07M 113.69M -67.76M -68.39M 28.74M 77.3M -50.12M n/a 15.69M n/a n/a n/a
Purchase of Investments
-28.59M -142.38M -126.03M -43.16M -157.33M -135M -80.57M -238.37M -88.6M -52.76M -102.17M -99.56M -3.94M -10.99M -22.62M -23.79M -37.71M -164.6M
Sales Maturities Of Investments
31.26M 127.3M 214.59M 117.23M 77.71M 199.55M 58.5M 124.68M 156.36M 121.16M 67.65M 22.26M 54.06M 45.53M 45.93M 26.55M 49M 45.25M
Other Investing Acitivies
n/a n/a n/a 74.05M n/a n/a -22.07M -113.69M 67.76M 68.39M -28.73M -77.3M 50.12M 34.53M -15.68M 2.75M 11.29M -119.35M
Investing Cash Flow
2.58M -16.26M 87.49M 147.29M -80.38M 64.11M -23.51M -114.02M 66.16M 67.45M -37.88M -78.04M 47.91M 32.98M 20.78M -2.24M 5.88M -121.73M
Debt Repayment
n/a n/a 4.08M n/a n/a -4.08M -3.13M -3.13M -3.13M -3.13M -3.13M -3.13M n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -24K n/a -37K -374K 490K n/a n/a n/a n/a n/a n/a -404K -7K -580K n/a -407K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-60K -180K 92.42M -74K -37K -374K n/a -3.57M 139.74M 960K 1K 642K 5.49M 760K 513K 963K -39K 1.83M
Financial Cash Flow
-60K 66K -24K 1.02M 96.49M -3.43M -3.13M -5.74M 137.66M 8.76M 12.22M 29.85M 5.49M 760K 506K 963K -39K 1.83M
Net Cash Flow
-42.2M -84.08M 15.73M 83.79M 25.57M -4.05M -12.57M -153.26M 172.62M 15.22M -49.52M 17.66M 50.21M -1.51M -293K -25.68M 574K -150.33M
Free Cash Flow
-44.81M -69.06M -72.81M -65.34M 8.7M -65.19M 12.63M -33.83M -32.8M -61.93M -27.23M 65.12M -5.39M -36.81M -24.12M -29.4M -10.68M -32.81M